Search

Helpdesk

Sales contact

Home > Resources > How a patient association gave rise to a company

How a patient association gave rise to a company

Patients insights Rare disease

25 April 2023

A patient association in rare diseases is first and foremost families who all have one thing in common: they need a cure to be found and made available.

Discover how French company AtmosR worked with a patient association to tackle the need to find a cure for Ondine:

Play Video

Follow us on social media

Subscribe to our newsletter

You may also like

Collecting PRO data in leukemia clinical research: the only way...

How to improve the collaboration between expert patients and healthcare...

Bringing the patient’s voice to clinical trials

Collecting PRO data in cancer trials: bringing the patient perspective...

“Dealing with multiple data sources in clinical trials” webcast

Improving the clinical trial journey with technology and system integration

About the author

Marc Chaperon

Estelle brings 20+ years of experience in pre-clinical and clinical research from Top 5 Pharma and Biotech firms. Leading projects across Phases 1 to 4 in diverse therapeutic areas, she offers deep insights into clinical science, operations, and regulatory intricacies. Appointed as Chief Medical Officer at Kayentis in May 2019.

Meet us at the following events

CNS SUMMIT 2024

10-13 NOV 2024 • Boston, USA

https://cnssummit.org/the-summit/

DMB 2024

13 NOV 2024 • Paris, France

https://dmb-asso.org/

SCOPE 2025

FEB 3-6 2025 • Orlando, USA

Booth #931 https://www.scopesummit.com/

Kayentis Europe
19 bis, chemin du vieux Chêne
38240 Meylan
France
Phone: +33 (0)4 76 00 54 20

Kayentis US
186 South Street
Suite 600
Boston, Massachusetts 02111
USA